cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Castle Biosciences Inc
8 own
7 watching
Current Price
$19.31
$0.11
(0.57%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
522.73M
52-Week High
52-Week High
26.70000
52-Week Low
52-Week Low
9.26000
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization522.73M
icon52-Week High26.70000
icon52-Week Low9.26000
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Castle Biosciences Inc do?
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient s tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Read More
How much money does Castle Biosciences Inc make?
News & Events about Castle Biosciences Inc.
Business Wire
9 months ago
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a study in JCO Precision Oncology1 in which...
Globe Newswire
9 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Comerica Incorporated (NYSE: CMA), Advance Auto Parts, Inc. (NYSE: AAP), EPAM Systems, Inc. (NYSE: EPAM), and Castle Biosciences, ...
Globe Newswire
10 months ago
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Texas Capital Bancshares, Inc. (NASDAQ: TCBI), EPAM Systems, Inc. (NYSE: EPAM), and Castle Biosciences, Inc. (NASDAQ: CSTL). Our ...
Business Wire
10 months ago
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Castle Biosciences, Inc. (Castle or the Company) (NASDAQ: CSTL) on behalf of Castle stockholders. Our investigation concerns whether Castle has violated the federal...
Globe Newswire
10 months ago
NEW YORK, June 13, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Castle Biosciences, Inc. (Castle or the Company) (NASDAQ: CSTL). The investigation concerns whether Castle and/or certain of its officers have violated the federal securities ...
Frequently Asked Questions
Frequently Asked Questions
What is Castle Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Castle Biosciences Inc shares?
plus_minus_icon
How can I buy Castle Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Castle Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Castle Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Castle Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Castle Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Castle Biosciences Inc?
plus_minus_icon
What percentage is Castle Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Castle Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$19.31
$0.11
(0.57%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00